Advertisement

Drugs

, Volume 36, Supplement 2, pp 6–10 | Cite as

Blood Lipid Levels and Antihypertensive Therapy

  • William C. Roberts
Article

Summary

The effects of elevated blood lipid concentrations on cardiovascular mortality and morbidity are reviewed, with particular emphasis on how high fat diets and antihypertensive drugs can influence the risk of developing atherosclerosis.

Keywords

Antihypertensive Therapy Blood Lipid Level Lipid Research Clinic Intrinsic Sympathomimetic Activity High Density Lipo 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amery A, Birkenhäger W, Bulpitt C, Clement D, Deruyltere M, et al. Influence of anti-hypertensive therapy on serum cholesterol in elderly hypertensive patients. Acta Cardiologica 37: 235–244, 1982PubMedGoogle Scholar
  2. Ames RP. Coronary heart disease and the treatment of hypertension: impact of diuretics on serum lipids and glucose. Journal of Cardiovascular Pharmacology 6: S466–S473, 1984PubMedCrossRefGoogle Scholar
  3. Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension. American Journal of Medicine 61: 748–757, 1976PubMedCrossRefGoogle Scholar
  4. Blackburn H. Coronary risk factors. How to evaluate and manage them. European Journal of Cardiology 2-3: 249–283, 1985Google Scholar
  5. Burris JF, Freis ED. Thiazides do not cause long-term increases in serum lipid concentrations. Archives of Internal Medicine 145: 2264–2266, 1985PubMedCrossRefGoogle Scholar
  6. Chobanian AV. Effects of beta blockers and other antihypertensive drugs on cardiovascular risk. American Journal of Cardiology 59: 48F–52F, 1987PubMedCrossRefGoogle Scholar
  7. Giuntoli F, Scalabrino A, Galeone F, Birindelli A, Natali A, et al. Antihypertensive and metabolic effects of a long-term treatment with acebutolol. Current Therapeutic Research 36: 188–194, 1984Google Scholar
  8. Goldman Al, Steel BW, Schnaper HW, Fritz A, Frohlich ED, et al. Serum lipoprotein levels during chlorthalidone therapy: a Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. Journal of the American Medical Association 244: 1691–1695, 1980PubMedCrossRefGoogle Scholar
  9. Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Annals of Internal Medicine 94: 7–11, 1981PubMedGoogle Scholar
  10. Helgeland A, Hjermann I, Holme I, Leren P. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. American Journal of Medicine 64: 34–38, 1978PubMedCrossRefGoogle Scholar
  11. Kannel WB, Gordon T, McGee D. Diuretics and serum cholesterol. Lancet 1: 1362–1363, 1977PubMedCrossRefGoogle Scholar
  12. Lasser NL, Grandits G, Caggiula AW, Cutler JA, Grimm Jr RH, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. American Journal of Medicine 76 (Suppl.): 52–66, 1984PubMedCrossRefGoogle Scholar
  13. Lehtonen A. Effect of beta blockers on blood lipid profile. American Heart Journal 109: 1192–1196, 1985PubMedCrossRefGoogle Scholar
  14. Leren P. Effect of alpha- and beta-blocker therapy on blood lipids: European experience. American Journal of Medicine 76: 67–71, 1985CrossRefGoogle Scholar
  15. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. Journal of the American Medical Association 251: 351–374, 1984CrossRefGoogle Scholar
  16. MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 5: 391–396, 1985PubMedCrossRefGoogle Scholar
  17. Middeke M, Weisweiler P, Schwandt P, Holzgreve H. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial. Clinical Cardiology 10: 94–98, 1987PubMedCrossRefGoogle Scholar
  18. Nakamura H. Effects of antihypertensive drugs on plasma lipids. American Journal of Cardiology 60: 24E–28E, 1987PubMedCrossRefGoogle Scholar
  19. Pool PE, Seagren SC, Salel AF, Skalland ML. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind placebo-controlled evaluation for systemic hypertension. American Journal of Cardiology 56: 86H–91H, 1985PubMedCrossRefGoogle Scholar
  20. Rifkind BM. The Lipid Research Clinics Coronary Primary Prevention Trial. Drugs 31(Suppl. 1): 53–60, 1986PubMedCrossRefGoogle Scholar
  21. Schiffl H, Weidmann P, Mordasini R, Riesen W, Bachmann C. Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the beta blocker pindolol. Metabolism 31: 411–415, 1982PubMedCrossRefGoogle Scholar
  22. Schoenfeld MR, Goldberger E. Hypercholesterolemia induced by thiazides: a pilot study. Current Therapeutic Research 6: 180–184, 1964PubMedGoogle Scholar
  23. van Brummelen P. The relevance of intrinsic sympathomimetic activity for β-blocker-induced changes in plasma lipids. Journal of Cardiovascular Pharmacology 5: S51–S55, 1983PubMedCrossRefGoogle Scholar
  24. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. II. Results of long-term treatment. Journal of the American Medical Association 248: 2004–2011, 1982CrossRefGoogle Scholar
  25. Wallace RB, Hunninghake DB, Chambless LE, Heiss G, Wahl P, et al. A screening survey of dyslipoproteinemias associated with prescription drug use. The Lipid Research Clinics Program Prevalence Study. Circulation 73(Suppl. I): I–70–I–79, 1986Google Scholar
  26. Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5: III–120–III–131, 1983CrossRefGoogle Scholar
  27. Weinberger MH. Antihypertensive therapy and lipids. Evidence, mechanisms and implications. Archives of Internal Medicine 145: 1102–1105, 1985PubMedCrossRefGoogle Scholar
  28. Williams WR, Borhani NO, Schnaper HW, Schneider KA, Slotkoff L, on behalf of the Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. The relationship between diuretics and serum cholesterol in HDFP participants (abstr.). Journal of the American College of Cardiology 1: 623, 1983CrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • William C. Roberts
    • 1
  1. 1.Pathology Branch, National Heart, Lung and Blood InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations